Health Professional Radio - Podcast
FDA Approval of ORIAHNN™ for Heavy Bleeding Due to Uterine Fibroids
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:08:20
- Mas informaciones
Informações:
Sinopsis
Dr. Ayman Al-Hendy, MD, discusses the recent FDA approval of AbbVie’s ORIAHNN™ (elagolix, estradiol, and norethindrone acetate capsules; elagolix capsules), a non-surgical, oral medication option, for premenopausal women to manage heavy bleeding due to uterine fibroids.
